• Disease areas
  • Products
  • Sustainable business
  • Partnering & innovation
  • Careers
  • About us
  • Patient help
  • Healthcare professionals
  • Investors
  • News & media
  • Contact us

Latest news

{{'Thu, 26 Jun 2025 11:09:00 -0400' | dateFormatUsFilter}}

Novo Nordisk continues efforts to support patient access to authentic, FDA approved Wegovy® and prioritize patient safety

Read more

{{'Mon, 23 Jun 2025 08:03:00 -0400' | dateFormatUsFilter}}

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing

Read more

{{'Sun, 22 Jun 2025 15:35:00 -0400' | dateFormatUsFilter}}

Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with hemophilia A in new phase 3 data presented at the ISTH 2025 Congress

Read more

News archive

Latest on compounded and counterfeit products and other important information about semaglutide.

Visit semaglutide.com

Career opportunities

Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.

NOVO NORDISK USA

800 Scudders Mill Road
Plainsboro, NJ 08536
Tel: 1-609-987-5800

 

Transparency in Employee Health Coverage:

Aetna
United Healthcare

Helpful links

Contact us Copyright Report a side effect or product complaint

Follow us

Facebook X (Twitter) Instagram

Other offices

Select location
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Privacy Policy
Consumer Health Data Privacy Notice
Cookie Policy
Privacy Request

change